01873 VIVA BIOTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.67X | Oper Margin | 17.6% |
|---|---|---|---|
| LT Debt/Equity | 19.2% | Net Margin | 8.4% |
| Total Debt/Equity | 33.8% | Return on Equity | 4.4% |
| Price/Book | 0.79X | Return on Assets | 2.4% |
| (HKD 1.500) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 177.92 | -127.98 | -592.53 | 351.70 | -459.15 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +239.0 | +78.4 | -268.5 | +176.6 | -254.5 |
| Earnings Per Share (HKD) | 0.083 | -0.066 | -0.309 | 0.184 | -0.292 |
| Earnings Per Share Growth (%) | +226.2 | +78.7 | -268.1 | +163.0 | -237.7 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | 0.027 |
| P/E* (X) | 18.01 | N/A | N/A | 8.15 | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | 1.80 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 1.896 | 1.881 | 2.089 | 2.474 | 2.325 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified # | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,987 | 2,156 | -7.8 | 2,380 |
| Operating Result | 297.707 | -56.237 | -629.4 | -370.904 |
| Associates | -0.095 | 0 | N/A | 0 |
| Profit Before Taxation | 295.705 | -55.953 | -628.5 | -459.165 |
| Taxation | 73.718 | 43.837 | +68.2 | 45.055 |
| Profit /( Loss) After Taxation | 221.987 | -99.79 | -322.5 | -504.22 |
| Minority Interests | 54.693 | 16.323 | +235.1 | 24.255 |
| Net Profit | 167.294 | -116.113 | -244.1 | -528.475 |
| Earnings Per Share () | 0.0833 | -0.0660 | -226.2 | -0.3093 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-03-27 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
